Baltimore, MD, United States of America

Ning Li


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 2001-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Ning Li in Radiopharmaceuticals

Introduction

Ning Li is an accomplished inventor based in Baltimore, MD (US). She has made significant contributions to the field of radiopharmaceuticals, holding a total of 3 patents. Her work focuses on developing compounds that can be used for therapeutic and diagnostic purposes in the treatment of neoplastic diseases.

Latest Patents

Ning Li's latest patents include innovative methods and compounds related to gastrin receptor-avid peptide conjugates. One of her notable inventions is a compound designed for use as a therapeutic or diagnostic radiopharmaceutical. This compound includes a group capable of complexing a medically useful metal, which is attached to a moiety that binds to a gastrin-releasing peptide receptor. Additionally, she has developed a method for treating subjects with neoplastic diseases by administering an effective amount of a radiopharmaceutical that has a metal chelated with a chelating group. This group is linked to a moiety that binds to the gastrin-releasing peptide receptor expressed on tumor cells, facilitating subsequent internalization within the cell. Another patent outlines a method for forming a therapeutic or diagnostic compound by reacting a metal synthon with a chelating group covalently linked to a moiety capable of binding to a gastrin-releasing peptide receptor.

Career Highlights

Ning Li is currently affiliated with the University of Missouri, where she continues her research and development in the field of radiopharmaceuticals. Her innovative work has positioned her as a key figure in advancing therapeutic options for cancer treatment.

Collaborations

Ning Li collaborates with esteemed colleagues, including Timothy J. Hoffman and Wynn A. Volkert. Their combined expertise enhances the research and development efforts in their field.

Conclusion

Ning Li's contributions to the field of radiopharmaceuticals demonstrate her commitment to advancing medical science. Her innovative patents and collaborative efforts are paving the way for new therapeutic options in the treatment of neoplastic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…